Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs iSpecimen Inc. (ISPC)

Advanced Biomed Inc. and iSpecimen Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $8.1M against $2.6M — 3.1× the size. iSpecimen Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −2,449.0%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 11 and iSpecimen Inc. on 1.

Valuation

Metric ADVB ISPC Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 2.75 4.37
P/B 0.41 0.74 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.06 24.35
EV/Sales n/m (1.11) 5.51
Earnings yield 129.37% (6,134.78%) (1.89%)
Free cash flow yield (90.81%) (846.31%) (0.15%)

Profitability

Metric ADVB ISPC Diagnostics & Research median
Gross margin — (108.26%) 50.89%
Operating margin 0.00% (2,020.05%) (8.57%)
Net margin 0.00% (2,449.02%) (6.37%)
Free cash flow margin 0.00% (1,866.61%) 0.00%
Return on equity 84.77% (968.44%) (2.92%)
Return on assets 36.47% (170.09%) (6.71%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB ISPC Diagnostics & Research median
Revenue growth (TTM) — (92.11%) 7.69%
EPS growth (last fiscal year) 266.53% 87.03% 25.92%
Revenue growth, 5-year CAGR — (25.10%) 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB ISPC Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 9.33 0.82 2.02
Net debt to EBITDA 0.06 0.95 0.70

Dividend

Metric ADVB ISPC Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB ISPC Diagnostics & Research median
Market cap 8.06m 2.60m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack